文献速递胃肠动力与功能性疾病食管胃疾病与幽门螺杆菌

膈式呼吸减少嗳气及质子泵抑制剂难治性胃食管反流症状

Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-12-22

这项前瞻性研究纳入36例质子泵抑制剂难治性胃食管反流病且嗳气视觉模拟评分≥6分的患者,15例接受标准化膈式呼吸训练、21例为等待名单对照。治疗组60%达到嗳气评分降低≥50%的主要终点而对照组为0%(P<.001),反流症状与生活质量亦改善并维持至治疗结束后4个月。

要点

  • 膈式呼吸训练使60%的质子泵抑制剂难治性胃食管反流伴嗳气患者嗳气评分降低≥50%,对照组为0%。
  • 治疗组嗳气视觉模拟评分由基线7.1±1.5降至治疗后3.5±2.0,对照组由7.6±1.1变为7.4±1.3。
  • 最终接受膈式呼吸治疗的36例中20例(55.6%)达到主要终点,均为过度胃上嗳气者。

核心结论

  • 前瞻性研究发现标准化膈式呼吸方案可减少质子泵抑制剂难治性胃食管反流病伴嗳气患者的嗳气及反流症状并提高生活质量,尤其对过度胃上嗳气者。

研究设计与样本

  • 前瞻性研究,连续纳入2015年4月至2016年10月新加坡一家三级医院胃肠科门诊的36例质子泵抑制剂难治性胃食管反流病且嗳气视觉模拟评分≥6分患者。
  • 15例进入标准化膈式呼吸训练组,21例进入等待名单对照组,对照期后最终也接受膈式呼吸治疗。
  • 患者在停用质子泵抑制剂期间接受高分辨率测压和24小时pH-阻抗监测。

主要发现

  • 治疗组15例中9例(60%)达到主要终点(嗳气视觉模拟评分降低≥50%),对照组21例中0例达到(P<.001)。
  • 治疗组平均嗳气视觉模拟评分由基线7.1±1.5降至膈式呼吸治疗后3.5±2.0,对照组由基线7.6±1.1变为等待期后7.4±1.3。
  • 治疗组80%患者嗳气频率显著减少,对照组为19%(P=.001)。
  • 反流疾病问卷平均评分治疗组降低12.2、对照组降低3.1(P=.01);反流生活质量简表平均评分治疗组增加15.4、对照组增加5.2(P=.04);EuroQoL视觉模拟评分治疗组增加15.7、对照组降低2.4。
  • 上述变化在治疗结束后4个月仍维持;最终接受膈式呼吸治疗的36例中20例(55.6%)达到主要终点,均为过度胃上嗳气者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In patients with gastroesophageal reflux disease (GERD) and excessive belching, most belches are supragastric, and can induce reflux episodes and worsen GERD. Supragastric belching (SGB) might be reduced with diaphragmatic breathing exercises. We investigated whether diaphragmatic breathing therapy is effective in reducing belching and proton pump inhibitor (PPI)-refractory gastroesophageal reflux symptoms. METHODS: We performed a prospective study of 36 consecutive patients with GERD refractory to PPI therapy and a belching visual analogue scale (VAS) score of 6 or more, seen at a gastroenterology clinic at a tertiary hospital in Singapore from April 2015 through October 2016. Patients underwent high-resolution manometry and 24-hour pH-impedance studies while they were off PPIs. Fifteen patients were placed on a standardized diaphragmatic breathing exercise protocol (treatment group) and completed questionnaires at baseline, after diaphragmatic breathing therapy, and 4 months after the therapy ended. Twenty-one patients were placed on a waitlist (control subjects), completed the same questionnaires with an additional questionnaire after their waitlist period, and eventually received diaphragmatic breathing therapy. The primary outcome was reduction in belching VAS by 50% or more after treatment. Secondary outcomes included GERD symptoms (evaluated using the reflux disease questionnaire) and quality of life (QoL) scores, determined from the Reflux-Qual Short Form and EuroQoL-VAS. RESULTS: Nine of the 15 patients in the treatment group (60%) and none of the 21 control subjects achieved the primary outcome (P < .001). In the treatment group, the mean belching VAS score decreased from 7.1 ± 1.5 at baseline to 3.5 ± 2.0 after diaphragmatic breathing therapy; in the control group, the mean VAS score was 7.6 ± 1.1 at baseline and 7.4 ± 1.3 after the waitlist period. Eighty percent of patients in the treatment group significantly reduced belching frequency compared with 19% in control subjects (P = .001). Treatment significantly reduced symptoms of GERD (the mean reflux disease questionnaire score decreased by 12.2 in the treatment group and 3.1 in the control group; P = .01). The treatment significantly increased QoL scores (the mean Reflux-Qual Short Form score increased by 15.4 in the treatment group and 5.2 in the control group; P = .04) and mean EuroQoL-VAS scores (15.7 increase in treatment group and 2.4 decrease in the control group). These changes were sustained at 4 months after treatment. In the end, 20 of the 36 patients who received diaphragmatic breathing therapy (55.6%), all with excessive SGB, achieved the primary outcome. CONCLUSIONS: In a prospective study, we found a standardized protocol for diaphragmatic breathing to reduce belching and PPI-refractory gastroesophageal reflux symptoms, and increase QoL in patients with PPI-refractory GERD with belching-especially those with excessive SGB.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ong AM, Chua LT, Khor CJ, et al. Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms. Clin Gastroenterol Hepatol. 2017. PMID: 29104130. doi:10.1016/j.cgh.2017.10.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。